Paul Waldman: I just want to highlight what you said there because it's so important, and this is fairly technical. You talked about these Mendelian randomizations, which are abbreviated MR, and similar to that, are genome-wide association studies called GWAS. And those are the evidence put forth by people who are preaching that APOB is a direct driver of cardiovascular disease. He says we need to treat the whole patient, not a biomarker; medicine shouldn't be an exact fine. Waldman: We should give patients numbers in a way that they can understand their hopes and anxieties without coercion.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode